Cargando…
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
Metformin is one of the treatments used for PCOS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial process in PCOS pathology. We have employed a lipidomic approach to explore altera...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831788/ https://www.ncbi.nlm.nih.gov/pubmed/31690730 http://dx.doi.org/10.1038/s41598-019-52263-w |